MEDS - Trxade Group - Stock Forecast

Pharmaceutical Retailers - Industry

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Trxade Group's activity chart (see below) currently has 6 price targets and 4 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by from JMP on 16-May-2023. First documented stock forecast 26-Feb-2021.

Allen Klee Constantine Davides

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 10-Dec-2021

$281.25

$273.71 (3630.11%)

$15187.49

Buy Since 26-Feb-2021

$393.75

$386.21 (5122.15%)

Show more analysts

What is MEDS (Trxade Group) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on MEDS (Trxade Group) with a proven track record?

ALLEN KLEE

Which analyst has the most public recommendations on MEDS (Trxade Group)?

Allen Klee works at MAXIM GROUP and has 3 price targets and 3 ratings on MEDS

Which analyst is the currently most bullish on MEDS (Trxade Group)?

Allen Klee with highest potential upside - $392.38

Which analyst is the currently most reserved on MEDS (Trxade Group)?

Constantine Davides with lowest potential downside - $273.71